HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angiotensin-converting enzyme 2 activation improves endothelial function.

Abstract
Diminished release and function of endothelium-derived nitric oxide coupled with increases in reactive oxygen species production is critical in endothelial dysfunction. Recent evidences have shown that activation of the protective axis of the renin-angiotensin system composed by angiotensin-converting enzyme 2, angiotensin-(1-7), and Mas receptor promotes many beneficial vascular effects. This has led us to postulate that activation of intrinsic angiotensin-converting enzyme 2 would improve endothelial function by decreasing the reactive oxygen species production. In the present study, we tested 1-[[2-(dimetilamino)etil]amino]-4-(hidroximetil)-7-[[(4-metilfenil)sulfonil]oxi]-9H-xantona-9 (XNT), a small molecule angiotensin-converting enzyme 2 activator, on endothelial function to validate this hypothesis. In vivo treatment with XNT (1 mg/kg per day for 4 weeks) improved the endothelial function of spontaneously hypertensive rats and of streptozotocin-induced diabetic rats when evaluated through the vasorelaxant responses to acetylcholine/sodium nitroprusside. Acute in vitro incubation with XNT caused endothelial-dependent vasorelaxation in aortic rings of rats. This vasorelaxation effect was attenuated by the Mas antagonist D-pro7-Ang-(1-7), and it was reduced in Mas knockout mice. These effects were associated with reduction in reactive oxygen species production. In addition, Ang II-induced reactive oxygen species production in human aortic endothelial cells was attenuated by preincubation with XNT. These results showed that chronic XNT administration improves the endothelial function of hypertensive and diabetic rat vessels by attenuation of the oxidative stress. Moreover, XNT elicits an endothelial-dependent vasorelaxation response, which was mediated by Mas. Thus, this study indicated that angiotensin-converting enzyme 2 activation promotes beneficial effects on the endothelial function and it is a potential target for treating cardiovascular disease.
AuthorsRodrigo A Fraga-Silva, Fabiana P Costa-Fraga, Tatiane M Murça, Patrícia L Moraes, Augusto Martins Lima, Roberto Q Lautner, Carlos H Castro, Célia Maria A Soares, Clayton L Borges, Ana Paula Nadu, Marilene L Oliveira, Vinayak Shenoy, Michael J Katovich, Robson A S Santos, Mohan K Raizada, Anderson J Ferreira
JournalHypertension (Dallas, Tex. : 1979) (Hypertension) Vol. 61 Issue 6 Pg. 1233-8 (Jun 2013) ISSN: 1524-4563 [Electronic] United States
PMID23608648 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • 1-((2-dimethylamino)ethylamino)-4-(hydroxymethyl)-7-((4-methylphenyl)sulfonyloxy)-9H-xanthene-9-one
  • Reactive Oxygen Species
  • Xanthones
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Ace2 protein, mouse
  • Ace2 protein, rat
  • Angiotensin-Converting Enzyme 2
Topics
  • Angiotensin-Converting Enzyme 2
  • Animals
  • Aorta, Thoracic (cytology, drug effects, metabolism)
  • Diabetes Mellitus, Experimental (metabolism, physiopathology)
  • Endothelium, Vascular (drug effects, metabolism, physiopathology)
  • Enzyme Activation
  • Humans
  • Hypertension (drug therapy, enzymology, physiopathology)
  • Immunohistochemistry
  • Male
  • Mice
  • Mice, Knockout
  • Oxidative Stress
  • Peptidyl-Dipeptidase A (drug effects, metabolism)
  • Radioimmunoassay
  • Rats
  • Rats, Sprague-Dawley
  • Rats, Wistar
  • Reactive Oxygen Species (antagonists & inhibitors, metabolism)
  • Vasodilation (drug effects, physiology)
  • Xanthones (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: